Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Berger

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Critical Care (London, England)|March 28, 2013
Sepsis biomarkers in unselected patients on admission to intensive or high-dependency careMartin J Llewelyn, Mario Berger, Mark Gregory, et al.
Clinical Chemistry and Laboratory Medicine|September 22, 2018
Analyzing the capability of PSP, PCT and sCD25 to support the diagnosis of infection in cancer patients with febrile neutropeniaLuis García de Guadiana-Romualdo, Enrique Jiménez-Santos, Pablo Cerezuela-Fuentes, et al.
Kidney International|September 29, 2023
A novel multi-ancestry proteome-wide Mendelian randomization study implicates extracellular proteins, tubular cells, and fibroblasts in estimated glomerular filtration rate regulationMatthew B Lanktree, Nicolas Perrot, Andrew Smyth, et al.
European Journal of Clinical Investigation|February 4, 2017
Pancreatic stone protein and soluble CD25 for infection and sepsis in an emergency departmentLuis García de Guadiana-Romualdo, Mario Berger, Enrique Jiménez-Santos, et al.
Biomarkers in Medicine|October 18, 2019
Prognostic performance of pancreatic stone protein in critically ill patients with sepsisLuis García de Guadiana-Romualdo, María Dolores Albaladejo-Otón, Mario Berger, et al.
Practical Laboratory Medicine|April 16, 2019
Analytical performance of a single epitope B-type natriuretic peptide sandwich immunoassay on the Minicare platform for point-of-care diagnosticsAlexander van Reenen, Mario Berger, Emmanuel Moreau, et al.
European Journal of Heart Failure|May 16, 2025
Effects of finerenone on natriuretic peptide levels in heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trialJonathan W Cunningham, Brian L Claggett, Muthiah Vaduganathan, et al.
JACC. Heart Failure|August 26, 2025
Temporal Changes in Biomarkers, Functional Status, and Quality of Life Prior to Adverse Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection FractionHenri Lu, Brian L Claggett, Muthiah Vaduganathan, et al.
JAMA Cardiology|March 28, 2026
EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF Trial: A Prespecified Secondary Analysis of FINEARTS-HFMisato Chimura, Kirsty McDowell, Pardeep S Jhund, et al.
JAMA|June 5, 2026
Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical TrialBrendon L Neuen, Vlado Perkovic, Rajiv Agarwal, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Critical Care (London, England)|March 28, 2013
Sepsis biomarkers in unselected patients on admission to intensive or high-dependency careMartin J Llewelyn, Mario Berger, Mark Gregory, et al.
Clinical Chemistry and Laboratory Medicine|September 22, 2018
Analyzing the capability of PSP, PCT and sCD25 to support the diagnosis of infection in cancer patients with febrile neutropeniaLuis García de Guadiana-Romualdo, Enrique Jiménez-Santos, Pablo Cerezuela-Fuentes, et al.
Kidney International|September 29, 2023
A novel multi-ancestry proteome-wide Mendelian randomization study implicates extracellular proteins, tubular cells, and fibroblasts in estimated glomerular filtration rate regulationMatthew B Lanktree, Nicolas Perrot, Andrew Smyth, et al.
European Journal of Clinical Investigation|February 4, 2017
Pancreatic stone protein and soluble CD25 for infection and sepsis in an emergency departmentLuis García de Guadiana-Romualdo, Mario Berger, Enrique Jiménez-Santos, et al.
Biomarkers in Medicine|October 18, 2019
Prognostic performance of pancreatic stone protein in critically ill patients with sepsisLuis García de Guadiana-Romualdo, María Dolores Albaladejo-Otón, Mario Berger, et al.
Practical Laboratory Medicine|April 16, 2019
Analytical performance of a single epitope B-type natriuretic peptide sandwich immunoassay on the Minicare platform for point-of-care diagnosticsAlexander van Reenen, Mario Berger, Emmanuel Moreau, et al.
European Journal of Heart Failure|May 16, 2025
Effects of finerenone on natriuretic peptide levels in heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trialJonathan W Cunningham, Brian L Claggett, Muthiah Vaduganathan, et al.
JACC. Heart Failure|August 26, 2025
Temporal Changes in Biomarkers, Functional Status, and Quality of Life Prior to Adverse Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection FractionHenri Lu, Brian L Claggett, Muthiah Vaduganathan, et al.
JAMA Cardiology|March 28, 2026
EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF Trial: A Prespecified Secondary Analysis of FINEARTS-HFMisato Chimura, Kirsty McDowell, Pardeep S Jhund, et al.
JAMA|June 5, 2026
Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical TrialBrendon L Neuen, Vlado Perkovic, Rajiv Agarwal, et al.
Pageof 2